Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AARSD1 MGC2744 ENSG00000266967 Alanyl-tRNA synthetase domain containing 1 17 42950526-42964498 Predicted intracellular proteins Evidence at protein level HPA021408, HPA022869, HPA023714 Supported Approved Nuclear membrane
Cytosol Renal cancer:1.67e-6 (unfavourable) Expressed in all Expressed in all testis: 99.0 ADPRH ARH1 ENSG00000144843 ADP-ribosylarginine hydrolase 3 119579268-119589945 Enzymes, Predicted intracellular proteins Evidence at protein level CAB001701, HPA036961 Approved Approved Nucleus
Nuclear membrane Breast cancer:2.42e-4 (favourable) Expressed in all Mixed lung: 20.2 AK9 AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954 ENSG00000155085 Adenylate kinase 9 6 109492856-109691217 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711 Approved Validated Nucleoplasm
Nuclear membrane Mixed Tissue enhanced testis: 31.1 parathyroid gland: 16.8 AKIRIN1 C1orf108, FLJ12666 ENSG00000174574 Akirin 1 1 38991223-39006059 Predicted intracellular proteins Evidence at protein level HPA051871 Approved Supported Nucleoplasm
Nuclear membrane Liver cancer:5.39e-7 (unfavourable) Expressed in all Expressed in all testis: 127.4 ANKRD17 FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16 ENSG00000132466 Ankyrin repeat domain 17 4 73073376-73258798 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA045024, HPA063731 Approved Supported Nucleus
Nuclear membrane Expressed in all Expressed in all parathyroid gland: 48.8 ARL6IP6 MGC33864 ENSG00000177917 ADP-ribosylation factor-like 6 interacting protein 6 2 152717893-152761253 Predicted membrane proteins Evidence at protein level HPA014743 Approved Approved Nuclear membrane
Cytosol Liver cancer:1.73e-4 (unfavourable), Renal cancer:2.14e-4 (unfavourable) Expressed in all Mixed placenta: 7.5 ATP6V1B1 ATP6B1, RTA1B, VATB, Vma2, VPP3 ENSG00000116039 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 2 70935882-70965406 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB009523, HPA031847 Supported Approved Nucleus
Nuclear membrane Group enriched Group enriched 10 breast: 16.0;cervix, uterine: 47.5;fallopian tube: 20.8;kidney: 64.5;placenta: 27.6;salivary gland: 67.0 skin: 4.2 BCL2 Bcl-2, PPP1R50 ENSG00000171791 B-cell CLL/lymphoma 2 18 63123346-63320128 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB000003, HPA055295 Supported Supported Nucleoplasm
Nuclear membrane Renal cancer:1.29e-8 (favourable), Cervical cancer:5.13e-5 (favourable), Thyroid cancer:2.47e-4 (unfavourable) Expressed in all Tissue enhanced thyroid gland: 69.2 parathyroid gland: 34.6 BRAP BRAP2, IMP, RNF52 ENSG00000089234 BRCA1 associated protein 12 111642146-111685986 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level HPA040357, HPA058820 Approved Supported Nuclear membrane
Cytosol Liver cancer:7.65e-6 (unfavourable) Expressed in all Tissue enriched 6 testis: 120.2 bone marrow: 21.2 BRIP1 BACH1, FANCJ, OF ENSG00000136492 BRCA1 interacting protein C-terminal helicase 1 17 61681266-61863521 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA005474 Approved Supported Nucleus
Nuclear membrane Colorectal cancer:3.45e-5 (favourable), Head and neck cancer:3.62e-4 (favourable) Mixed Tissue enhanced testis: 14.4 bone marrow: 5.0 BTNL9 BTN8, FLJ32535 ENSG00000165810 Butyrophilin-like 9 5 181040225-181061523 Predicted membrane proteins Evidence at protein level HPA043429 Approved Nuclear membrane
Vesicles Liver cancer:1.55e-9 (favourable), Endometrial cancer:7.51e-4 (unfavourable) Mixed Tissue enhanced adipose tissue: 166.7 lung: 56.0 C12orf45 MGC40397 ENSG00000151131 Chromosome 12 open reading frame 45 12 104986310-105049737 Predicted intracellular proteins Evidence at protein level HPA038722 Uncertain Approved Nucleoplasm
Nuclear membrane Renal cancer:4.58e-10 (unfavourable) Expressed in all Expressed in all thyroid gland: 25.8 CADM4 IGSF4C, Necl-4, SynCAM4, TSLL2 ENSG00000105767 Cell adhesion molecule 4 19 43622368-43639839 Predicted membrane proteins Evidence at protein level HPA012612 Supported Approved Nucleus
Nuclear membrane Renal cancer:2.28e-6 (favourable) Expressed in all Tissue enhanced cerebral cortex: 164.1 parathyroid gland: 58.8 CCDC34 L15, NY-REN-41, RAMA3 ENSG00000109881 Coiled-coil domain containing 34 11 27330827-27363868 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA037574 Uncertain Approved Nuclear membrane
Nucleoli fibrillar center Liver cancer:1.32e-7 (unfavourable), Renal cancer:1.82e-4 (unfavourable), Ovarian cancer:8.52e-4 (favourable) Expressed in all Tissue enhanced testis: 54.6 fallopian tube: 13.4 CDS1 ENSG00000163624 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 4 84582979-84651338 Enzymes, Predicted membrane proteins Evidence at protein level HPA036187 Uncertain Approved Nucleus
Nuclear membrane Renal cancer:0.00e+0 (favourable), Colorectal cancer:5.22e-4 (favourable) Expressed in all Mixed fallopian tube: 49.0 CERS2 FLJ10243, LASS2, SP260 ENSG00000143418 Ceramide synthase 2 1 150960583-150975004 Predicted membrane proteins Evidence at protein level HPA027262 Approved Supported Nuclear membrane
Endoplasmic reticulum Expressed in all Expressed in all liver: 408.6 CES3 ES31, FLJ21736 ENSG00000172828 Carboxylesterase 3 16 66961237-66975148 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA041008, HPA041307 Approved Approved Nuclear membrane
Endoplasmic reticulum Liver cancer:7.26e-5 (favourable) Mixed Tissue enhanced colon: 37.9;duodenum: 31.3;rectum: 34.8 small intestine: 27.1 CLK1 ENSG00000013441 CDC-like kinase 1 2 200853009-200864744 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB033141, HPA062405 Approved Supported Nucleoplasm
Nuclear membrane Urothelial cancer:2.28e-4 (favourable) Expressed in all Expressed in all bone marrow: 113.8 CLPTM1 ENSG00000104853 Cleft lip and palate associated transmembrane protein 1 19 44954585-44993341 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA068702 Approved Nuclear membrane
Microtubule organizing center Expressed in all Expressed in all parathyroid gland: 127.5 CPNE1 CPN1 ENSG00000214078 Copine I 20 35626031-35664956 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA047259, HPA072634 Approved Supported Nucleoplasm
Nuclear membrane Renal cancer:2.74e-10 (unfavourable) Expressed in all Expressed in all smooth muscle: 102.7 CRAT CAT1 ENSG00000095321 Carnitine O-acetyltransferase 9 129094810-129111189 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level HPA019230, HPA020260, HPA022815 Supported Approved Nucleoplasm
Nuclear membrane Renal cancer:0.00e+0 (favourable), Endometrial cancer:2.36e-4 (favourable) Expressed in all Expressed in all testis: 116.2 CTD-2192J16.24 ENSG00000269590 19 12664828-12669397 Predicted intracellular proteins Evidence at protein level HPA065685 Approved Nuclear membrane
Endoplasmic reticulum Not detected Tissue enhanced lymph node: 2.0 cerebral cortex,duodenum: 1.3 DCTN5 MGC3248, p25 ENSG00000166847 Dynactin 5 (p25) 16 23641392-23677455 Predicted intracellular proteins Evidence at protein level HPA042003, HPA063710 Approved Supported Nucleoplasm
Nuclear membrane Liver cancer:4.02e-4 (unfavourable), Renal cancer:4.48e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 38.2 DHRS4 FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2 ENSG00000157326 Dehydrogenase/reductase (SDR family) member 4 14 23953586-23969279 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA023972 Uncertain Approved Nuclear membrane
Vesicles Renal cancer:4.55e-6 (favourable) Expressed in all Expressed in all kidney: 149.2 DHRS4L2 SDR25C3 ENSG00000187630 Dehydrogenase/reductase (SDR family) member 4 like 2 14 23969874-24006408 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA023972 Uncertain Uncertain Nuclear membrane
Vesicles Ovarian cancer:3.21e-4 (favourable) Expressed in all Expressed in all kidney: 121.8 DIRAS3 ARHI, NOEY2 ENSG00000162595 DIRAS family, GTP-binding RAS-like 3 1 68045962-68051631 Predicted intracellular proteins Evidence at protein level HPA028483, HPA028557, HPA029384 Approved Approved Nuclear membrane
Cytosol Breast cancer:9.21e-4 (favourable), Renal cancer:9.21e-4 (favourable) Mixed Tissue enhanced ovary: 70.8 parathyroid gland: 24.8 DNAH3 DKFZp434N074, DLP3, Dnahc3b, Hsadhc3 ENSG00000158486 Dynein, axonemal, heavy chain 3 16 20933111-21159441 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA062493 Approved Nuclear membrane
Intermediate filaments Mixed Group enriched 5 fallopian tube: 8.0;testis: 5.9 lung: 1.3 DOCK11 ACG, FLJ32122, FLJ43653, ZIZ2 ENSG00000147251 Dedicator of cytokinesis 11 X 118495898-118686163 Predicted intracellular proteins Evidence at protein level HPA059695 Uncertain Approved Nuclear membrane
Nucleoli Head and neck cancer:4.87e-4 (favourable) Expressed in all Mixed adipose tissue: 33.9 DTX2 KIAA1528, RNF58 ENSG00000091073 Deltex 2, E3 ubiquitin ligase 7 76461676-76505995 Predicted intracellular proteins Evidence at protein level HPA042931 Approved Supported Nucleoplasm
Nuclear membrane Renal cancer:1.13e-8 (unfavourable), Glioma:7.25e-4 (unfavourable) Expressed in all Expressed in all esophagus: 37.3 DUSP2 PAC-1 ENSG00000158050 Dual specificity phosphatase 2 2 96143166-96145440 Enzymes, Predicted intracellular proteins Evidence at protein level HPA071920 Supported Nucleus
Nuclear membrane Renal cancer:4.97e-5 (unfavourable) Expressed in all Tissue enhanced bone marrow: 79.1;seminal vesicle: 85.3 lymph node: 51.5 EIF2B4 DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta ENSG00000115211 Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa 2 27364352-27370486 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB032234, HPA039993 Uncertain Approved Nuclear membrane
Actin filaments Renal cancer:5.46e-8 (unfavourable), Liver cancer:1.83e-4 (unfavourable) Expressed in all Expressed in all testis: 51.8 EMD LEMD5, STA ENSG00000102119 Emerin X 154379197-154381523 Disease related genes, Predicted membrane proteins Evidence at protein level HPA000609, CAB001545, CAB002029, CAB062552 Supported Validated Nuclear membrane
Endoplasmic reticulum Expressed in all Expressed in all fallopian tube: 32.3 FAM135B C8ORFK32 ENSG00000147724 Family with sequence similarity 135, member B 8 138130023-138496822 Predicted intracellular proteins Evidence at transcript level HPA023911, HPA023950, HPA024815 Uncertain Approved Nucleoplasm
Nuclear membrane Tissue enhanced Group enriched 7 adrenal gland: 3.6;cerebral cortex: 8.3;testis: 7.2 colon: 0.8 FAM169A KIAA0888 ENSG00000198780 Family with sequence similarity 169, member A 5 74777574-74866951 Predicted intracellular proteins Evidence at protein level HPA041574 Supported Supported Nuclear membrane
Cytosol Mixed Tissue enhanced cerebral cortex: 29.3;testis: 25.1 epididymis: 20.5 FAM181B LOC220382, MGC33846 ENSG00000182103 Family with sequence similarity 181, member B 11 82729941-82733864 Predicted intracellular proteins Evidence at transcript level HPA066861 Approved Approved Nuclear membrane
Mitochondria Endometrial cancer:8.07e-4 (favourable) Tissue enriched Tissue enriched 20 cerebral cortex: 17.5 adrenal gland,fallopian tube: 0.8 FAM188A C10orf97, CARP, DERP5, FLJ13397, my042 ENSG00000148481 Family with sequence similarity 188, member A 10 15778170-15860520 Predicted intracellular proteins Evidence at protein level HPA038400, HPA038406 Uncertain Supported Nucleoplasm
Nuclear membrane Expressed in all Expressed in all testis: 39.0 FUT11 MGC33202 ENSG00000196968 Fucosyltransferase 11 (alpha (1,3) fucosyltransferase) 10 73772291-73780251 Predicted secreted proteins Evidence at protein level HPA014033 Approved Approved Nuclear membrane
Golgi apparatus Cervical cancer:2.39e-6 (unfavourable), Renal cancer:3.67e-4 (unfavourable), Breast cancer:6.78e-4 (unfavourable) Expressed in all Mixed placenta: 24.8 FZR1 CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242 ENSG00000105325 Fizzy/cell division cycle 20 related 1 19 3506273-3538330 Predicted intracellular proteins Evidence at protein level HPA043536 Approved Supported Nucleoplasm
Nuclear membrane Cervical cancer:1.75e-4 (favourable), Endometrial cancer:2.57e-4 (favourable) Expressed in all Expressed in all testis: 33.1 GLE1 GLE1L, hGLE1, LCCS1 ENSG00000119392 GLE1 RNA export mediator 9 128504700-128542288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level HPA041689, HPA043538, HPA061560 Supported Supported Nuclear membrane
Nucleoli Stomach cancer:7.04e-4 (favourable), Endometrial cancer:7.49e-4 (favourable) Expressed in all Expressed in all testis: 58.6 GPR183 EBI2 ENSG00000169508 G protein-coupled receptor 183 13 99294530-99307405 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA028847, CAB033690 Uncertain Approved Nuclear membrane
Vesicles Cervical cancer:9.77e-4 (favourable) Expressed in all Mixed appendix: 117.8 GPR37 EDNRBL, hET(B)R-LP, PAELR ENSG00000170775 G protein-coupled receptor 37 (endothelin receptor type B-like) 7 124745997-124765627 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA042903, HPA068009 Approved Approved Nuclear membrane
Cytosol Lung cancer:6.00e-5 (unfavourable), Ovarian cancer:7.26e-4 (favourable) Tissue enhanced Tissue enhanced cerebral cortex: 78.9;testis: 27.6 placenta: 12.7 GRB10 ENSG00000106070 Growth factor receptor-bound protein 10 7 50590063-50793462 Cancer-related genes, Predicted intracellular proteins Evidence at protein level CAB019423, HPA027502, HPA031818 Approved Approved Nuclear membrane
Vesicles Expressed in all Expressed in all thyroid gland: 44.8 GTF3C3 TFIIIC102, TFiiiC2-102 ENSG00000119041 General transcription factor IIIC, polypeptide 3, 102kDa 2 196763032-196799725 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA069179 Supported Nucleus
Nuclear membrane Liver cancer:1.26e-6 (unfavourable) Expressed in all Expressed in all parathyroid gland: 40.1 GTPBP4 CRFG, FLJ10686, FLJ10690, NGB, NOG1 ENSG00000107937 GTP binding protein 4 10 988019-1019936 Predicted intracellular proteins Evidence at protein level HPA039618, HPA056468 Uncertain Validated Nuclear membrane
Nucleoli Liver cancer:8.85e-12 (unfavourable), Renal cancer:2.38e-5 (unfavourable), Endometrial cancer:4.57e-4 (unfavourable) Expressed in all Expressed in all testis: 37.2 HAND1 bHLHa27, eHand, Hxt, Thing1 ENSG00000113196 Heart and neural crest derivatives expressed 1 5 154474972-154478264 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA040925 Approved Uncertain Nucleus
Nuclear membrane Group enriched Tissue enhanced smooth muscle: 16.6 adrenal gland: 6.3 HFE HLA-H ENSG00000010704 Hemochromatosis 6 26087281-26098343 Disease related genes, Predicted membrane proteins Evidence at protein level HPA017276, HPA053470 Approved Approved Nuclear membrane
Mitochondria Expressed in all Mixed parathyroid gland: 27.3 HOXA7 HOX1, HOX1A ENSG00000122592 Homeobox A7 7 27153716-27157936 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA074048 Approved Nucleoplasm
Nuclear membrane Renal cancer:1.15e-5 (favourable), Endometrial cancer:7.87e-5 (unfavourable) Mixed Mixed epididymis: 22.3 INPP4A INPP4 ENSG00000040933 Inositol polyphosphate-4-phosphatase type I A 2 98444854-98594390 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA001628 Approved Approved Nucleus
Nuclear membrane Endometrial cancer:3.70e-6 (unfavourable) Expressed in all Expressed in all cerebral cortex: 38.8 KIAA0930 bK268H5.C22.1, C22orf9 ENSG00000100364 KIAA0930 22 45190338-45240769 Predicted intracellular proteins Evidence at protein level HPA038091 Uncertain Approved Nuclear membrane
Mitochondria Liver cancer:6.90e-8 (unfavourable), Renal cancer:8.95e-7 (unfavourable), Endometrial cancer:9.22e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 76.4 KIAA1549 ENSG00000122778 KIAA1549 7 138831381-138981318 Cancer-related genes, Disease related genes, Predicted membrane proteins Evidence at protein level HPA019560 Approved Approved Nuclear membrane
Intermediate filaments Renal cancer:3.93e-7 (favourable) Mixed Mixed seminal vesicle: 10.4 KIAA1586 ENSG00000168116 KIAA1586 6 57046532-57055239 Predicted intracellular proteins Evidence at protein level HPA036370 Approved Approved Nucleus
Nuclear membrane Expressed in all Mixed testis: 14.0 KIAA1614 ENSG00000135835 KIAA1614 1 180913154-180951614 Predicted intracellular proteins Evidence at protein level HPA028227, HPA061684 Approved Approved Nuclear membrane
Vesicles Mixed Mixed thyroid gland: 3.0 KRT77 KRT1B ENSG00000189182 Keratin 77, type II 12 52689626-52703463 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA045934 Supported Approved Nuclear membrane
Plasma membrane Mixed Tissue enriched 12 skin: 309.5 breast: 25.9 LCORL FLJ30696, MLR1 ENSG00000178177 Ligand dependent nuclear receptor corepressor-like 4 17841199-18021876 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level HPA028794, HPA028795, HPA060033 Uncertain Supported Nucleoplasm
Nuclear membrane Colorectal cancer:9.65e-4 (favourable) Expressed in all Mixed testis: 11.6 MFSD10 IT10C3, TETRAN ENSG00000109736 Major facilitator superfamily domain containing 10 4 2930561-2934859 Predicted membrane proteins Evidence at protein level HPA043209 Uncertain Approved Nucleoplasm
Nuclear membrane Renal cancer:5.68e-5 (unfavourable), Liver cancer:4.49e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 41.3 MRGPRF GPR140, GPR168, MGC21621, mrgF ENSG00000172935 MAS-related GPR, member F 11 69004395-69013409 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA028811 Approved Supported Nuclear membrane
Plasma membrane Expressed in all Mixed smooth muscle: 77.8 MRPS14 HSMRPS14 ENSG00000120333 Mitochondrial ribosomal protein S14 1 175010789-175023425 Predicted secreted proteins, Ribosomal proteins Evidence at protein level HPA051087 Uncertain Supported Nuclear membrane
Mitochondria Expressed in all Expressed in all thyroid gland: 38.8 MRPS23 CGI-138, HSPC329, MRP-S23 ENSG00000181610 Mitochondrial ribosomal protein S23 17 57834781-57850056 Predicted intracellular proteins Evidence at protein level HPA023453 Supported Supported Nuclear membrane
Mitochondria Liver cancer:9.52e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 61.2 MSTO1 FLJ10504, LST005, misato, MST ENSG00000125459 Misato 1, mitochondrial distribution and morphology regulator 1 155610205-155614967 Predicted intracellular proteins Evidence at protein level HPA005899, HPA005914 Approved Approved Nuclear membrane
Cytosol Renal cancer:0.00e+0 (unfavourable), Liver cancer:1.90e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 23.4 MX1 IFI-78K, MxA ENSG00000157601 MX dynamin-like GTPase 1 21 41420304-41459214 Predicted intracellular proteins Evidence at protein level HPA030917, HPA030918, HPA049724 Approved Approved Supported Nuclear membrane
Cytosol Renal cancer:1.57e-4 (unfavourable) Expressed in all Expressed in all spleen: 120.4 NAV3 KIAA0938, POMFIL1 ENSG00000067798 Neuron navigator 3 12 77830905-78213008 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA032111, HPA032112, CAB037063 Uncertain Approved Nuclear membrane
Cytosol Mixed Tissue enhanced cerebral cortex: 23.1;ovary: 22.9 spleen: 12.1 NDUFB4 B15 ENSG00000065518 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa 3 120596309-120602500 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA051739 Supported Supported Nuclear membrane
Mitochondria Urothelial cancer:1.79e-4 (favourable) Expressed in all Expressed in all adrenal gland: 365.9 NEK1 KIAA1901, NY-REN-55 ENSG00000137601 NIMA-related kinase 1 4 169393275-169612629 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA020873, HPA040413 Approved Approved Nuclear membrane
Nucleoli Renal cancer:1.42e-4 (favourable) Expressed in all Mixed testis: 22.3 NLRP10 CLR11.1, NALP10, NOD8, PAN5, Pynod ENSG00000182261 NLR family, pyrin domain containing 10 11 7959424-7965426 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA039498, HPA040101 Uncertain Approved Nucleoplasm
Nuclear membrane Tissue enhanced Tissue enriched 7 skin: 3.2 epididymis: 0.4 NSUN3 FLJ22609 ENSG00000178694 NOP2/Sun domain family, member 3 3 94062916-94128545 Predicted intracellular proteins Evidence at protein level HPA036181, HPA057979 Uncertain Approved Nucleoplasm
Nuclear membrane Expressed in all Mixed testis: 8.0 NTRK3 TRKC ENSG00000140538 Neurotrophic tyrosine kinase, receptor, type 3 15 87859751-88256768 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level CAB009233, HPA027484, HPA048065 Supported Supported Nuclear membrane
Nucleoli Tissue enhanced Tissue enhanced cerebral cortex: 39.7 testis: 15.2 NUP50 NPAP60L ENSG00000093000 Nucleoporin 50kDa 22 45163841-45188015 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level HPA047162, HPA048328 Supported Validated Nucleoplasm
Nuclear membrane Stomach cancer:4.06e-4 (favourable) Expressed in all Expressed in all testis: 54.5 NUP62 DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI ENSG00000213024 Nucleoporin 62kDa 19 49906825-49929763 Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level HPA005435, CAB020724 Supported Supported Nuclear membrane
Vesicles Renal cancer:5.71e-12 (unfavourable), Liver cancer:2.50e-7 (unfavourable) Expressed in all Expressed in all testis: 76.8 PHF11 BCAP, IGER, NY-REN-34 ENSG00000136147 PHD finger protein 11 13 49495610-49528987 Predicted intracellular proteins Evidence at protein level HPA016566, HPA016708 Uncertain Supported Nucleoplasm
Nuclear membrane Renal cancer:4.46e-7 (unfavourable), Endometrial cancer:7.98e-6 (favourable), Urothelial cancer:3.46e-4 (favourable) Expressed in all Expressed in all thyroid gland: 57.4 PLRG1 Cwc1, PRL1, Prp46, PRPF46, TANGO4 ENSG00000171566 Pleiotropic regulator 1 4 154535006-154550435 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA035931, HPA035932, HPA061486 Supported Validated Nuclear membrane
Nuclear speckles Renal cancer:8.20e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 65.7 POM121 DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A ENSG00000196313 POM121 transmembrane nucleoporin 7 72879365-72951440 Predicted intracellular proteins, Transporters Evidence at protein level CAB003710, HPA043809, HPA049817 Approved Validated Nucleoplasm
Nuclear membrane Expressed in all Expressed in all cerebral cortex: 30.2 POM121C ENSG00000272391 POM121 transmembrane nucleoporin C 7 75416787-75486271 Predicted intracellular proteins Evidence at transcript level HPA043809, HPA049817 Approved Approved Nucleoplasm
Nuclear membrane Expressed in all Expressed in all thyroid gland: 27.8 POMZP3 POM-ZP3, POM121 ENSG00000146707 POM121 and ZP3 fusion 7 76609986-76627261 Predicted intracellular proteins Evidence at transcript level HPA049817 Uncertain Approved Nucleoplasm
Nuclear membrane Liver cancer:3.78e-4 (unfavourable), Cervical cancer:4.34e-4 (favourable), Ovarian cancer:9.31e-4 (favourable) Expressed in all Mixed testis: 13.7 PTGES3L-AARSD1 ENSG00000108825 PTGES3L-AARSD1 readthrough 17 42950526-42980528 Predicted intracellular proteins Evidence at protein level HPA021408, HPA022869, HPA023714 Approved Approved Nuclear membrane
Cytosol Not detected Tissue enhanced smooth muscle: 7.4 testis: 4.0 RAB29 RAB7L, RAB7L1 ENSG00000117280 RAB29, member RAS oncogene family 1 205767986-205775460 Predicted intracellular proteins Evidence at protein level CAB020822, HPA026303 Approved Approved Nuclear membrane
Nucleoli Endometrial cancer:1.82e-5 (unfavourable), Liver cancer:1.61e-4 (unfavourable) Expressed in all Expressed in all kidney: 75.6 RABAC1 PRA1, PRAF1, YIP3 ENSG00000105404 Rab acceptor 1 (prenylated) 19 41956681-41959390 Predicted membrane proteins Evidence at protein level CAB019320, HPA029171 Supported Approved Nuclear membrane
Nucleoli fibrillar center Expressed in all Expressed in all cerebral cortex: 107.6 RADIL FLJ10324, KIAA1849, RASIP2 ENSG00000157927 Ras association and DIL domains 7 4797055-4883719 Predicted intracellular proteins Evidence at protein level HPA051776 Uncertain Approved Nucleus
Nuclear membrane Mixed Tissue enhanced testis: 9.5 lung: 4.3 RAMP1 ENSG00000132329 Receptor (G protein-coupled) activity modifying protein 1 2 237858893-237912114 FDA approved drug targets, Predicted membrane proteins Evidence at protein level HPA057814 Approved Nucleoplasm
Nuclear membrane Stomach cancer:1.68e-4 (unfavourable), Liver cancer:7.61e-4 (favourable) Expressed in all Tissue enhanced endometrium: 233.7 smooth muscle: 169.4 RANBP2 ADANE, ANE1, NUP358 ENSG00000153201 RAN binding protein 2 2 108719481-108785811 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564 Supported Validated Nuclear membrane
Vesicles Expressed in all Expressed in all parathyroid gland: 73.6 RAP1GAP2 GARNL4, KIAA1039 ENSG00000132359 RAP1 GTPase activating protein 2 17 2777056-3037739 Predicted intracellular proteins Evidence at protein level HPA022148, HPA022896 Approved Supported Nuclear membrane
Cytosol Renal cancer:1.36e-6 (favourable) Expressed in all Mixed cerebral cortex: 35.1 RB1CC1 ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131 ENSG00000023287 RB1-inducible coiled-coil 1 8 52622456-52745843 Predicted intracellular proteins Evidence at protein level HPA024391, HPA053049 Approved Supported Nuclear membrane
Cytosol Endometrial cancer:1.61e-4 (unfavourable) Expressed in all Expressed in all testis: 63.1 RBMX2 CGI-79, Snu17 ENSG00000134597 RNA binding motif protein, X-linked 2 X 130401969-130413343 Predicted intracellular proteins Evidence at protein level HPA026609 Approved Approved Nuclear membrane
Nucleoli Renal cancer:8.44e-9 (unfavourable), Liver cancer:7.04e-4 (unfavourable), Lung cancer:9.15e-4 (favourable) Expressed in all Expressed in all endometrium: 29.2 RCC1 CHC1 ENSG00000180198 Regulator of chromosome condensation 1 1 28505943-28539300 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB015413, HPA027573, HPA027574 Supported Supported Nucleus
Nuclear membrane Renal cancer:2.43e-11 (unfavourable), Liver cancer:1.91e-5 (unfavourable) Expressed in all Expressed in all testis: 63.6 RFX7 FLJ12994, RFXDC2 ENSG00000181827 Regulatory factor X, 7 15 56087280-56243266 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA035462 Supported Approved Nucleus
Nuclear membrane Renal cancer:1.12e-5 (unfavourable) Expressed in all Mixed testis: 8.3 RGPD1 RGP1 ENSG00000187627 RANBP2-like and GRIP domain containing 1 2 86907953-87013981 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Approved Nuclear membrane
Vesicles Not detected Group enriched 8 cervix, uterine: 12.6;placenta: 14.2;testis: 44.0 bone marrow: 2.8 RGPD2 RANBP2L2, RGP2 ENSG00000185304 RANBP2-like and GRIP domain containing 2 2 87755955-87825952 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Approved Nuclear membrane
Vesicles Not detected Tissue enhanced testis: 13.1 placenta: 8.3 RGPD3 RGP3 ENSG00000153165 RANBP2-like and GRIP domain containing 3 2 106391290-106468376 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Approved Nuclear membrane
Vesicles Not detected Tissue enriched 13 testis: 11.7 cerebral cortex,kidney: 0.9 RGPD4 DKFZp686P0288, RGP4 ENSG00000196862 RANBP2-like and GRIP domain containing 4 2 107826937-107890841 Predicted intracellular proteins Evidence at transcript level HPA049497, HPA051675, HPA067564 Uncertain Uncertain Nuclear membrane
Vesicles Not detected Tissue enriched 58 testis: 5.7 all non-specific tissues: 0.0 RGPD5 BS-63, DKFZp686I1842, RGP5 ENSG00000015568 RANBP2-like and GRIP domain containing 5 2 109792758-109857695 Predicted intracellular proteins Evidence at protein level HPA045704, HPA049497, HPA051675, HPA067564 Uncertain Uncertain Nuclear membrane
Vesicles Not detected Tissue enhanced testis: 6.8 duodenum: 3.2 RGPD6 RGP6 ENSG00000183054 RANBP2-like and GRIP domain containing 6 2 110513812-110577185 Predicted intracellular proteins Evidence at protein level HPA045704, HPA049497, HPA051675, HPA067564 Uncertain Uncertain Nuclear membrane
Vesicles Not detected Expressed in all testis: 82.8 RGPD8 RanBP2alpha, RANBP2L1 ENSG00000169629 RANBP2-like and GRIP domain containing 8 2 112370092-112434488 Predicted intracellular proteins Evidence at protein level HPA045704, HPA049497, HPA051675, HPA067564 Uncertain Uncertain Nuclear membrane
Vesicles Not detected Tissue enriched 5 testis: 31.6 cerebral cortex: 5.8 RIN1 ENSG00000174791 Ras and Rab interactor 1 11 66330242-66336840 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level HPA035491 Uncertain Approved Nucleus
Nuclear membrane Renal cancer:9.34e-7 (unfavourable), Endometrial cancer:2.21e-4 (favourable) Expressed in all Tissue enhanced skin: 19.3 cerebral cortex,stomach: 5.2 SCAI C9orf126, FLJ36664, NET40 ENSG00000173611 Suppressor of cancer cell invasion 9 124942608-125143506 Predicted intracellular proteins Evidence at protein level HPA020632 Approved Supported Nucleus
Nuclear membrane Mixed Mixed cerebral cortex: 11.8 SCN3B HSA243396 ENSG00000166257 Sodium channel, voltage gated, type III beta subunit 11 123629187-123655244 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level HPA042518 Approved Nuclear membrane
Cytokinetic bridge Tissue enhanced Tissue enriched 11 cerebral cortex: 132.5 adrenal gland: 11.6 SEC11A SEC11L1, sid2895, SPC18, SPCS4A ENSG00000140612 SEC11 homolog A, signal peptidase complex subunit 15 84669538-84716716 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA047533 Approved Nuclear membrane
Golgi apparatus Endometrial cancer:1.94e-5 (favourable), Head and neck cancer:5.99e-5 (unfavourable), Thyroid cancer:2.95e-4 (favourable) Expressed in all Expressed in all thyroid gland: 211.4 SEC11C SEC11L3, SPC21, SPCS4C ENSG00000166562 SEC11 homolog C, signal peptidase complex subunit 18 59139477-59158836 Enzymes, Predicted membrane proteins Evidence at protein level HPA026816, HPA047533 Approved Approved Nuclear membrane
Golgi apparatus Expressed in all Expressed in all prostate: 275.4 SIPA1L3 KIAA0545 ENSG00000105738 Signal-induced proliferation-associated 1 like 3 19 37907228-38208372 Predicted intracellular proteins Evidence at protein level HPA042072, HPA045480 Uncertain Approved Nuclear membrane
Nuclear speckles Expressed in all Mixed small intestine: 20.2 SIX2 ENSG00000170577 SIX homeobox 2 2 45005161-45009430 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA052782, HPA056958 Uncertain Supported Nucleoplasm
Nuclear membrane Mixed Group enriched 5 cervix, uterine: 18.6;parathyroid gland: 8.5;prostate: 6.1;salivary gland: 9.5;skeletal muscle: 6.7 adipose tissue: 1.9 SLC16A3 MCT3, MCT4 ENSG00000141526 Solute carrier family 16 (monocarboxylate transporter), member 3 17 82228397-82261129 Predicted membrane proteins, Transporters Evidence at protein level CAB017490, HPA021451 Approved Supported Nuclear membrane
Plasma membrane Liver cancer:1.19e-7 (unfavourable), Renal cancer:3.71e-7 (unfavourable), Lung cancer:2.02e-5 (unfavourable), Cervical cancer:6.07e-4 (unfavourable) Expressed in all Expressed in all skeletal muscle: 74.4 SMPD4 FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3 ENSG00000136699 Sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) 2 130151392-130182750 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA046279, HPA049426 Approved Approved Nuclear membrane
Cytosol Renal cancer:8.16e-8 (unfavourable), Liver cancer:8.37e-6 (unfavourable), Endometrial cancer:7.47e-5 (unfavourable), Prostate cancer:1.73e-4 (unfavourable) Expressed in all Expressed in all testis: 36.3 SNAPC4 FLJ13451, PTFalpha, SNAP190 ENSG00000165684 Small nuclear RNA activating complex, polypeptide 4, 190kDa 9 136375577-136398797 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA046627, HPA073243 Uncertain Approved Nucleoplasm
Nuclear membrane Pancreatic cancer:4.52e-5 (favourable) Expressed in all Expressed in all testis: 14.1 SSPN KRAG, SPN1, SPN2 ENSG00000123096 Sarcospan 12 26121991-26299290 Predicted membrane proteins Evidence at protein level HPA066432 Approved Nucleus
Nuclear membrane Renal cancer:2.77e-5 (unfavourable) Mixed Mixed cervix, uterine: 64.1 SYNE1 8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B ENSG00000131018 Spectrin repeat containing, nuclear envelope 1 6 152121684-152637801 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA019113 Approved Supported Nucleoplasm
Nuclear membrane Mixed Expressed in all parathyroid gland: 58.0 TAF3 TAF140, TAFII140 ENSG00000165632 TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa 10 7818504-8016627 Predicted intracellular proteins Evidence at protein level HPA066184 Supported Nucleoplasm
Nuclear membrane Liver cancer:2.14e-7 (unfavourable), Renal cancer:5.01e-4 (unfavourable) Expressed in all Mixed testis: 14.1 TBC1D19 FLJ11082 ENSG00000109680 TBC1 domain family, member 19 4 26576437-26755351 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA039592 Approved Approved Nucleoplasm
Nuclear membrane Renal cancer:1.21e-7 (favourable), Thyroid cancer:4.06e-4 (unfavourable) Expressed in all Mixed parathyroid gland: 22.7 TCHHL1 S100A17, THHL1 ENSG00000182898 Trichohyalin-like 1 1 152084144-152089064 Predicted intracellular proteins Evidence at protein level HPA042579, HPA063483 Supported Approved Nuclear membrane
Nucleoli Not detected Not detected epididymis: 0.1 TET1 bA119F7.1, CXXC6, KIAA1676, LCX ENSG00000138336 Tet methylcytosine dioxygenase 1 10 68560656-68694482 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level CAB014886, HPA019032, HPA057273 Approved Supported Nucleus
Nuclear membrane Tissue enriched Mixed parathyroid gland: 2.4 TFPT amida, FB1, INO80F ENSG00000105619 TCF3 (E2A) fusion partner (in childhood Leukemia) 19 54107013-54115675 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA034958, HPA058534 Approved Supported Nucleoplasm
Nuclear membrane Pancreatic cancer:3.13e-4 (favourable), Colorectal cancer:5.13e-4 (unfavourable), Liver cancer:5.25e-4 (unfavourable) Expressed in all Mixed cerebral cortex: 10.6 TIGD3 ENSG00000173825 Tigger transposable element derived 3 11 65354767-65357613 Predicted intracellular proteins Evidence at transcript level HPA040016 Uncertain Approved Nucleoplasm
Nuclear membrane Mixed Tissue enhanced small intestine: 2.4;testis: 3.9 cerebral cortex: 1.7 TMEM109 MGC5508 ENSG00000110108 Transmembrane protein 109 11 60913874-60923443 Predicted membrane proteins, Transporters Evidence at protein level HPA011785 Approved Approved Nuclear membrane
Cytosol Urothelial cancer:2.68e-4 (unfavourable) Expressed in all Expressed in all endometrium: 94.2 TMEM154 FLJ32028 ENSG00000170006 Transmembrane protein 154 4 152618632-152680165 Predicted membrane proteins Evidence at protein level HPA019184, HPA055411 Uncertain Approved Nucleoplasm
Nuclear membrane Mixed Tissue enhanced esophagus: 64.6;skin: 69.4 tonsil: 25.3 TMEM175 MGC4618 ENSG00000127419 Transmembrane protein 175 4 932387-958656 Predicted membrane proteins, Transporters Evidence at protein level HPA057160 Approved Approved Nucleus
Nuclear membrane Pancreatic cancer:9.85e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 20.8 TMEM201 NET5, RP13-15M17.2 ENSG00000188807 Transmembrane protein 201 1 9588922-9614873 Predicted membrane proteins Evidence at protein level CAB039039 Approved Supported Nucleus
Nuclear membrane Liver cancer:9.61e-8 (unfavourable), Cervical cancer:5.36e-4 (favourable) Expressed in all Mixed testis: 9.9 TNKS PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1 ENSG00000173273 Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 8 9555914-9782346 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level HPA025690 Approved Approved Nucleoplasm
Nuclear membrane Expressed in all Expressed in all testis: 52.7 TOR1A DQ2, DYT1 ENSG00000136827 Torsin family 1, member A (torsin A) 9 129812944-129824134 Disease related genes, Predicted secreted proteins Evidence at protein level CAB012473, HPA051195 Approved Supported Nuclear membrane
Vesicles Lung cancer:5.45e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 39.8 TRAPPC11 C4orf41, FLJ12716, foigr, gry ENSG00000168538 Trafficking protein particle complex 11 4 183659267-183713594 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA045427 Approved Nucleoplasm
Nuclear membrane Renal cancer:2.66e-5 (favourable) Expressed in all Expressed in all parathyroid gland: 36.6 TTLL2 C6orf104, dJ366N23.3, NYD-TSPG ENSG00000120440 Tubulin tyrosine ligase-like family member 2 6 167325086-167359503 Predicted intracellular proteins Evidence at protein level HPA027985 Approved Nuclear membrane
Nucleoli Not detected Tissue enriched 58 testis: 33.9 liver: 0.5 UPK3A UPK3 ENSG00000100373 Uroplakin 3A 22 45284982-45295874 Disease related genes, Predicted membrane proteins Evidence at protein level HPA018407, HPA018415 Supported Uncertain Nuclear membrane
Nuclear bodies Group enriched Group enriched 7 parathyroid gland: 12.8;prostate: 33.5;skeletal muscle: 12.6;urinary bladder: 16.0 thyroid gland: 2.6 YEATS4 GAS41, NuBI-1, YAF9 ENSG00000127337 YEATS domain containing 4 12 69359703-69390796 Predicted intracellular proteins Evidence at protein level HPA072532 Approved Nucleoplasm
Nuclear membrane Liver cancer:3.52e-6 (unfavourable) Expressed in all Expressed in all testis: 68.8 ZBED6CL C7orf29 ENSG00000188707 ZBED6 C-terminal like 7 150329789-150332721 Predicted intracellular proteins Evidence at transcript level HPA019724, HPA055805 Approved Approved Nuclear membrane
Vesicles Renal cancer:1.38e-5 (unfavourable), Pancreatic cancer:2.44e-5 (favourable), Glioma:5.65e-5 (unfavourable), Breast cancer:9.48e-5 (favourable) Expressed in all Tissue enhanced adrenal gland: 31.9;parathyroid gland: 30.0 lymph node: 10.0 ZBTB1 KIAA0997, ZNF909 ENSG00000126804 Zinc finger and BTB domain containing 1 14 64503712-64533690 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA050516 Approved Supported Nucleoplasm
Nuclear membrane Head and neck cancer:4.92e-4 (favourable) Expressed in all Expressed in all bone marrow: 53.6 ZC3H12C KIAA1726, MCPIP3 ENSG00000149289 Zinc finger CCCH-type containing 12C 11 110093361-110171841 Predicted intracellular proteins Evidence at protein level HPA038836, HPA038837 Approved Approved Nuclear membrane
Golgi apparatus Renal cancer:9.90e-6 (favourable) Expressed in all Mixed thyroid gland: 13.6 ZC3H13 DKFZp434D1812, KIAA0853 ENSG00000123200 Zinc finger CCCH-type containing 13 13 45954465-46052759 Predicted intracellular proteins Evidence at protein level HPA039340, HPA040140, HPA047806 Uncertain Approved Nuclear membrane
Actin filaments Renal cancer:2.69e-4 (favourable) Expressed in all Expressed in all cerebral cortex: 33.6 ZC3HC1 NIPA ENSG00000091732 Zinc finger, C3HC-type containing 1 7 130018286-130051451 Predicted intracellular proteins Evidence at protein level HPA019089, HPA024023 Supported Supported Nucleus
Nuclear membrane Liver cancer:1.02e-6 (unfavourable), Endometrial cancer:3.36e-4 (unfavourable) Expressed in all Expressed in all testis: 26.4 ZNF124 HZF-16, HZF16 ENSG00000196418 Zinc finger protein 124 1 247121975-247172016 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA031127 Uncertain Approved Nucleus
Nuclear membrane Urothelial cancer:1.03e-4 (favourable) Expressed in all Mixed salivary gland: 16.8 ZNF224 BMZF-2, KOX22, ZNF255, ZNF27 ENSG00000267680 Zinc finger protein 224 19 44094339-44109886 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA054045 Approved Supported Nucleus
Nuclear membrane Urothelial cancer:1.53e-7 (favourable), Renal cancer:5.32e-4 (unfavourable) Expressed in all Expressed in all spleen: 36.1 ZNF292 bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16 ENSG00000188994 Zinc finger protein 292 6 87152833-87264196 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level HPA032154, HPA050618 Uncertain Approved Nucleus
Nuclear membrane Expressed in all Expressed in all endometrium,ovary: 17.0 ZNF329 FLJ12586 ENSG00000181894 Zinc finger protein 329 19 58126252-58155110 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA044373 Uncertain Approved Nucleoplasm
Nuclear membrane Renal cancer:8.58e-9 (favourable) Expressed in all Mixed parathyroid gland: 16.3 ZNF354C KID3 ENSG00000177932 Zinc finger protein 354C 5 179060415-179083537 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA030904 Uncertain Supported Nuclear membrane
Cytosol Mixed Mixed ovary: 9.2 ZNF383 FLJ35863 ENSG00000188283 Zinc finger protein 383 19 37217926-37248738 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA063945 Approved Supported Nucleus
Nuclear membrane Urothelial cancer:3.71e-4 (favourable), Pancreatic cancer:9.97e-4 (favourable) Expressed in all Mixed thyroid gland: 9.3 ZNF442 FLJ14356 ENSG00000198342 Zinc finger protein 442 19 12345949-12365905 Predicted intracellular proteins, Transcription factors Evidence at transcript level HPA045738, HPA053407 Uncertain Approved Nuclear membrane
Vesicles Mixed Mixed ovary: 6.0 ZNF749 FLJ16360 ENSG00000186230 Zinc finger protein 749 19 57435329-57445485 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA042082, HPA042091, HPA056001 Uncertain Approved Nucleoplasm
Nuclear membrane Expressed in all Mixed parathyroid gland: 4.2